Articles published by Daiichi Sankyo
DS-9606 Shows Promising Preliminary Clinical Activity in Patients with Advanced Solid Tumors
September 15, 2024
From Daiichi Sankyo
Via Business Wire
Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070
August 06, 2024
From Daiichi Sankyo
Via Business Wire
Tickers
MRK
IDeate-Lung02 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Relapsed Small Cell Lung Cancer
August 01, 2024
From Daiichi Sankyo
Via Business Wire
Tickers
MRK
From Daiichi Sankyo
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|